Volitionrx (VNRX) Revenue Growth (1y) (2020 - 2026)
Volitionrx (VNRX) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.30% |
| 10 | Volitionrx | 1.13 Mn | -1.66 Mn | - | -1.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.97% |
| Dec 31, 2025 | 203.93% |
| Sep 30, 2025 | 54.47% |
| Jun 30, 2025 | -12.44% |
| Mar 31, 2025 | 46.14% |
| Dec 31, 2024 | 77.62% |
| Sep 30, 2024 | 218.44% |
| Jun 30, 2024 | 29.31% |
| Mar 31, 2024 | 16.71% |
| Dec 31, 2023 | 166.68% |
| Sep 30, 2023 | 540.11% |
| Jun 30, 2023 | 444.15% |
| Mar 31, 2023 | 26.48% |
| Dec 31, 2022 | -806.98% |
| Sep 30, 2022 | -21.82% |
| Jun 30, 2022 | 60.41% |
| Mar 31, 2022 | 347.36% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 4,331.83% |
| Jun 30, 2021 | 377.13% |